Publications
146
Citations
1,879
Est. group size
~9
Recurring co-author estimate
Active years
29
Publishing since 1998
Typically publishes in teams of ~10 · 5% small-team papers (≤3 authors) · across 34 venues
- Sa1799 PERSONALIZED PHENOTYPE-BASED INTERVENTIONS MITIGATE HORMONAL ADAPTATIONS AND ENHANCE SATIETY IN OBESITY MANAGEMENT: EVIDENCE FROM A NON-RANDOMIZED CLINICAL TRIAL
Gastrointestinal Endoscopy · 2026
- Sa1799 PERSONALIZED PHENOTYPE-BASED INTERVENTIONS MITIGATE HORMONAL ADAPTATIONS AND ENHANCE SATIETY IN OBESITY MANAGEMENT: EVIDENCE FROM A NON-RANDOMIZED CLINICAL TRIAL
Gastroenterology · 2026
- 1194 PERFORMANCE OF A MACHINE LEARNING-ASSISTED GENE RISK SCORE FOR CALORIES-TO-SATIATION TO PREDICT WEIGHT LOSS AFTER SLEEVE GASTRECTOMY: 8-YEAR EXPERIENCE
Gastrointestinal Endoscopy · 2026
- 1081 NOVEL ALGORITHM TO UNDERSTAND THE OBESITY TREATMENT JOURNEY: REAL-WORLD TRAJECTORIES AND PRELIMINARY OUTCOMES
Gastroenterology · 2026
- 1081 NOVEL ALGORITHM TO UNDERSTAND THE OBESITY TREATMENT JOURNEY: REAL-WORLD TRAJECTORIES AND PRELIMINARY OUTCOMES
Gastrointestinal Endoscopy · 2026
- 1194 PERFORMANCE OF A MACHINE LEARNING-ASSISTED GENE RISK SCORE FOR CALORIES-TO-SATIATION TO PREDICT WEIGHT LOSS AFTER SLEEVE GASTRECTOMY: 8-YEAR EXPERIENCE
Gastroenterology · 2026
- Sex, Not Age, Predicts Weight Loss Outcomes With Tirzepatide: A Retrospective Analysis
Obesity · 2026
- Phenotype tailored lifestyle intervention for weight management in individuals with emotional eating: A secondary analysis of the PHENO-Diet trial
Obesity Pillars · 2026
- Real-World Comparative Effectiveness of Tirzepatide and Semaglutide for Obesity: A Multicentered Study
Mayo Clinic Proceedings · 2026
- SAT-688 One-Year Real-World Weight Loss Outcomes with Tirzepatide in Postmenopausal Women with and without Hormone Therapy
Journal of the Endocrine Society · 2025
- Su2065: COMPARATIVE REAL-WORLD ANALYSIS OF WEIGHT LOSS OUTCOMES AND SIDE EFFECT PROFILES BETWEEN SEMAGLUTIDE AND TIRZEPATIDE: A MULTICENTERED STUDY
Gastroenterology · 2025
- Su2064: THE ASSOCIATION BETWEEN DIABETES SEVERITY SCORE AND WEIGHT LOSS OUTCOMES OF TIRZEPATIDE: A MULTICENTERED STUDY
Gastroenterology · 2025
- MON-829 Sex-Specific Cardiometabolic Benefits of Tirzepatide: A Real-World Study on ASCVD Risk Mitigation
Journal of the Endocrine Society · 2025
- S811 Metabolic and Bariatric Surgery vs Glucagon-Like Peptide-1 Receptor Agonist Therapy: A Head-to-Head Comparison of Cardiometabolic Risk Profiles
The American Journal of Gastroenterology · 2025
- Glucagon-like Receptor-1 agonists for obesity: Weight loss outcomes, tolerability, side effects, and risks
Obesity Pillars · 2024
- Gastroenterology×33
- Diabetes Care×17
- Journal of the Endocrine Society×11
- The American Journal of Gastroenterology×9
- Diabetes×8
- Chelsea R. Hutch
Medicine · University of Michigan
- Colleen Barclay
Medicine · The Ohio State University
- Eugênio Cersósimo
Medicine · University of Michigan
- Robert R. Henry
Medicine · University of Michigan
- Jingchuan Guo
Medicine · Purdue University West Lafayette
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile